Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Alnylam Pharmaceuticals Inc. (ALNY)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Slate Path Capital

David Greenspan

480,000 $42,010 5.63%
2. 735,000 $64,327 4.72%
3.
Great Point Partners

Jeffrey Jay And David Kroin

300,000 $26,256 +16% 4.09%
4.
Bridger Management

Roberto Mignone

723,010 $63,278 +13% 3.66%
5.
Sectoral Asset Management

Jerome Pfund And Michael Sjostrom

384,041 $33,611 +27% 3.56%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$71.87 297,501 Large Shareholder 10,554,134 2017-05-31 Filing
$65.35 11,500 Officer 11,500 2017-05-30 Filing
$37.00 27,900 Director 27,900 2016-10-13 Filing
$58.36 2,000 Director 4,000 2016-03-09 Filing
$69.75 205,030 Large Shareholder 10,256,633 2016-02-01 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$120.00 2,500 Officer 1,916 2018-08-30 Filing
$106.25 1,400 Officer, Director 151,297 2018-07-25 Filing
$105.83 34,995 Officer, Director 152,697 2018-07-25 Filing
$104.83 7,758 Officer, Director 187,692 2018-07-25 Filing
$103.69 3,847 Officer, Director 195,450 2018-07-25 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 1,370,538 $119,949 3.17%
2. 389,072 $34,052 2.03%
3. 140,826 $12,325 1.81%
4. 52,800 $3,543 1.68%
5. 27,684 $2,423 1.58%
News See All